New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
12:06 EDTBBEP, SFLY, CHRW, BPI, NVSHigh option volume stocks: BBEP SFLY CHRW BPI NVS
News For BBEP;SFLY;CHRW;BPI;NVS From The Last 14 Days
Check below for free stories on BBEP;SFLY;CHRW;BPI;NVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
10:33 EDTSFLYOptions with decreasing implied volatility
Subscribe for More Information
September 22, 2014
16:07 EDTNVSAnacor announces commercial launch of KERYDIN topical solution in U.S.
Subscribe for More Information
12:26 EDTSFLYShutterfly in talks to be taken private for over $50 per share, Reuters says
Subscribe for More Information
12:21 EDTSFLYShutterfly calls active, in advanced talks to be bought by Silver Lake, report
Subscribe for More Information
12:16 EDTSFLYShutterfly near highs of session, up about 5%
12:10 EDTSFLYShutterfly in advanced talks to be bought by Silver Lake, Reuters says
Subscribe for More Information
11:42 EDTBBEPBreitBurn Energy sees second half adjusted EBITDA $235M-$255M
Subscribe for More Information
September 18, 2014
07:17 EDTBPIBMO Capital to hold a conference
14th Annual Back to School Education Conference to be held in New York on September 18 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link
September 17, 2014
07:35 EDTBBEPImperial Capital to hold a conference
Subscribe for More Information
September 16, 2014
07:31 EDTNVSEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
September 15, 2014
07:27 EDTNVSIBC Life Sciences to hold a conference
Subscribe for More Information
07:21 EDTNVSHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 12, 2014
15:29 EDTSFLYHP exploring sale of Snapfish photo service, Reuters reports
Subscribe for More Information
15:26 EDTSFLYHP exploring sale of Snapfish photo service, Reuters reports
Subscribe for More Information
05:18 EDTNVSNovartis announces new data confirms high efficacy of Gilenya in achieving NEDA
Novartis announced new analyses presented at the Joint ACTRIMS-ECTRIMS Meeting in Boston, USA, which confirmed the high efficacy of Gilenya in achieving 'no evidence of disease activity', or NEDA, in people with relapsing-remitting multiple sclerosis, or RRMS, across four key disease measures - relapses, MRI lesions, brain shrinkage and disability progression. Specifically, patients taking Gilenya had a more than four-times greater likelihood of achieving NEDA across these four key measures. NEDA is currently defined as having no relapses, MRI lesions and disability progression. These new analyses from the phase III FREEDOMS and FREEDOMS II trials reinforce the value of including brain shrinkage to the definition of NEDA. The inclusion of brain shrinkage into the NEDA definition would allow physicians to obtain a more complete assessment of a patient's disease, including the underlying damage in MS.
September 10, 2014
10:00 EDTCHRWOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:43 EDTCHRWC.H. Robinson initiated with an Equal Weight at Barclays
Target $70.
05:17 EDTNVSNovartis Gilenya data confirms reducing brain shrinkage matter for MS patients
Subscribe for More Information
September 9, 2014
07:55 EDTNVSOphthotech earlier than expected Novartis payment positive, says Oppenheimer
After Ophthotech (OPHT) received a $50M Phase 3 enrollment payment from Novartis (NVS) earlier than expected, Oppenheimer thinks the payment highlights an underappreciated stock driver for Opthotech, and demonstrates that recent suggestions of Phase 3 enrollment timelines possibly slipping are unwarranted. The firm believes the company is executing well on the Fovista Phase 3 program and keeps an Outperform rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use